Plain-English translation of NCT05919433 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a detection and outreach program designed to identify patients with primary biliary cholangitis — a rare, slowly progressive liver disease caused by the immune system attacking bile ducts — who may have fallen out of medical care. Researchers will search hospital databases to find patients with specific blood test markers of this disease, then contact them to reconnect them with treatment. The goal is to make sure no patient with this condition is left without the care and medication they need.
Studies show that about one in three patients diagnosed with primary biliary cholangitis stop coming to their appointments and are lost to follow-up, missing out on life-extending treatments. This program exists to find those 'lost' patients and bring them back into care, because early treatment can slow disease progression and prevent serious liver damage.
You likely qualify if…
You likely don't qualify if…
If you are identified in the hospital database as having markers of this disease, the research team will reach out to you. They will review your existing medical records and test results to confirm your diagnosis, and work with you to reconnect you with appropriate medical care and treatment if needed. This is primarily a records-based study, so there are no new invasive tests required from you — the focus is on finding you and helping you access the treatment you may need.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Spain